Tostadin, a novel antibacterial peptide from an antagonistic microorganism Brevibacillus brevis XDH

Bioresource Technology

Volumn 111, Issue , 2012, Pages 504-506

  Song, Zhen ^a   Liu, Qingxin ^a   Guo, Hui ^a,b   Ju, Ruicheng ^a   Zhao, Yuhua ^a   Li, Jinyu ^a   Liu, Xunli ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Antibacterial peptide; Brevibacillus brevis; Characterization; Purification

Indexed keywords

AMMONIUM SULFATE PRECIPITATION; ANTAGONISTIC BACTERIA; ANTIBACTERIAL PEPTIDES; BREVIBACILLUS BREVIS; CATION EXCHANGE CHROMATOGRAPHY; DATA SUPPORT; FERMENTATION MEDIUM; IN-VITRO; LINEAR PEPTIDES; LIQUID CULTURE; MASS SPECTRA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS; THERMALLY STABLE;

AMINO ACIDS; BACTERIA; CHARACTERIZATION; CHROMATOGRAPHY; ESCHERICHIA COLI; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PURIFICATION;

PEPTIDES;

AMINO ACID; AMMONIUM SULFATE; POLYPEPTIDE ANTIBIOTIC AGENT; TOSTADIN; UNCLASSIFIED DRUG; WATER;

AMINO ACID; AMMONIUM; ANTAGONISM; ANTIMICROBIAL ACTIVITY; BACTERIUM; CHROMATOGRAPHY; FERMENTATION; ION EXCHANGE; NUCLEAR MAGNETIC RESONANCE; PEPTIDE; PRECIPITATION (CHEMISTRY); PURIFICATION; SOIL MICROORGANISM; SOLUBILIZATION; SULFATE; TEMPERATURE EFFECT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; BREVIBACILLUS BREVIS; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; FERMENTATION; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS; THERMOSTABILITY;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BREVIBACILLUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; CULTURE MEDIA; FERMENTATION; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY;

CHINA;

BACTERIA (MICROORGANISMS); BREVIBACILLUS BREVIS; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84862782258     PISSN: 09608524     EISSN: 18732976     Source Type: Journal    
DOI: 10.1016/j.biortech.2012.02.051     Document Type: Article

References (15)

1. Cambau E., Matrat S., Pan X.S., Bettoni R.R., Corbel C., Aubry A., Lascols C., Driot J.Y., Fisher L.M. Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. J. Antimicrob. Chemother. 2009, 63:443-450.
2. Dale B.A., Fredericks L.P. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr. Issues Mol. Biol. 2005, 7:119-133.
3. Eaton P., Fernandes C.J., Pereira E., Pintado M.E., Malcata F.X. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. Ultramicroscopy 2008, 108:1128-1134.
4. Elmar J.P., Ruthven N.L., Ronald N.M. The interaction of the antimicrobial peptide gramicidin S with lipid bilayer model and biological membranes. Biochim. Biophys. Acta 1999, 1462:201-221.
5. Frueh D.P., Arthanari H., Koglin A., Vosburg D.A., Bennett A.E., Walsh C.T., Wagner G. Dynamic thiolation-thioesterase structure of a non-ribosomal peptide synthetase. Nature 2008, 454:903-906.
6. Gauri S.S., Mandal S.M., Pati B.R., Dey S. Purification and structural characterization of a novel antibacterial peptide from Bellamya bengalensis: activity against ampicillin and chloramphenicol resistant Staphylococcus epidermidis. Peptides 2011, 32:691-696.
7. Mogi T., Kita K. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol. Life Sci. 2009, 66:3821-3826.
8. Saikia R., Gogoi D.K., Mazumder S., Yadav A., Sarma R.K., Bora T.C., Gogoi B.K. Brevibacillus laterosporus strain BPM3, a potential biocontrol agent isolated from a natural hot water spring of Assam. Indian Microbiol. Res. 2010, 10.1016/j.micres. 2010.03.002.
9. Shida O., Takagi H., Kadowaki K., Komagata K. Proposal for two newgenera Brevibacillus gen. nov. and Aneurini-bacillus gen. nov. Int. J. Syst. Bacteriol. 1996, 46:939-946.
10. Song Z., Liu K., Lu C., Yu J., Ju R., Liu X. Isolation and characterization of a potential biocontrol Brevibacillus laterosporus. Afr. J. Microbiol. Res. 2011, 18:2675-2681.
11. Song Z., Liu X., Lu C., Yu J., Ju R., Zhao Y., Li J., Liu K. Medium optimization for the antibacterial substances production from Brevibacillus Brevis XDH using response surface methodology. Adv. Mater. Res. 2012, 345:355-360.
12. Viscardi M., Perugini A.G., Auriemma C., Capuano F., Morabito S., Kim K.P., Loessner M.J., Iovane G. Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Int. J. Antimicrob. Agents 2008, 31:152-157.
13. Wang J., Haddad N.I., Yang S.Z., Mu B.Z. Structural characterization of lipopeptides from Brevibacillus brevis HOB1. Appl. Biochem. Biotechnol. 2010, 160:812-821.
14. Zhang B., Xie C., Yang X. A novel small antifungal peptide from Bacillus strain B-TL2 isolated from tobacco stems. Peptides 2008, 29:350-355.
15. Zhao Z., Wang Q., Wang K., Brian K., Liu C., Gu Y. Study of the antifungal activity of Bacillus vallismortis ZZ185 in vitro and identification of its antifungal components. Bioresour. Technol. 2010, 101:292-297.